Follow last change Dec 2003 re-read 3 minutes ago

M4N

Developed for: head and neck neoplasm
Investigated by: Duke University · Erimos Pharmaceuticals · Medical University of South Carolina

today NCT00057512 · Ph 1

2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 1	NCT00057512	Jan → Dec 2003	head and neck neoplasm	Erimos Pharmaceuticals	Completed	No outcome recorded

Every value below carries the sentence it was read from. 1 source stands behind the page.

Field	Value	Cited text
Known as	M4N	ClinicalTrials.gov intervention name — accepted as the source's own label NCT00057512 ↗
Route	Other	“administered intratumorally” NCT00057512 ↗